Endoscopic ultrasound (EUS)-guided pancreatic anti-tumoral therapy

Mayo Clinic gastroenterologist Michael J. Levy, M.D., of the Rochester, Minnesota, campus, discusses the use of endoscopic ultrasound (EUS)-guided pancreatic anti-tumoral therapy for the treatment of pancreatic masses. This overview addresses the safety, current status, efficacy, and potential advantages and disadvantages associated with these local ablation options: chemotherapy, alcohol and radiofrequency ablation.

Related Presenters

Michael Levy, MD.

Michael Levy, MD

Dr. Levy is a physician specializing in gastroenterology with subspecialty certification in pancreatobiliary disease. Areas of clinical expertise include: Pancreatic disorders Endoscopic ultrasound (EUS) Endoscopic retrograde cholangiopancreatography ...

View full profile